Craig-Hallum Sticks to Their Buy Rating for Maravai Lifesciences Holdings (MRVI)
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply ...
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
TriLink, Aldevron enter into license and supply pact for CleanCap
TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
MarketWatch4 天
Maravai LifeSciences Holdings Inc.
Grifols S.A. Cl B-0.23% €5.2B Grifols S.A.-1.24% €5.2B ...
Forbes6 天
Maravai LifeSciences Holdings
Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and ...
英为财情6 天
Maravai Lifesciences期权链
免费获得Maravai Lifesciences(MRVI)期权数据。查看选定到期日的Maravai Lifesciences个股期权的认购、认沽执行价格、最新价、涨跌幅、成交量及更多股票期权相关信息。点击“分析”可查看Maravai Lifesciences Holdings Inc股票期权的未平仓合约分析表格。